Tonix Pharmaceuticals, IncChatham, New Jersey, United States
1218: Randomized, Double-Blind, Placebo-Controlled Confirmatory Phase 3 Trial of Bedtime Sublingual Cyclobenzaprine (TNX-102 SL) in Fibromyalgia
Sunday, November 17, 202410:30 AM – 12:30 PM Eastern Time
No financial relationships with ineligible companies to disclose